Literature DB >> 838198

Glucagon levels in normal and diabetic subjects: use of a specific immunoabsorbent for glucagon radioimmunoassay.

F P Alford, S R Bloodm, J D Nabarro.   

Abstract

Non-specific plasma effects may produce major errors in the estimation of true plasma pancreatic glucagon concentrations by radioimmunoassay. This has been circumvented by the production of glucagon-free plasma for each individual investigated, by means of glucagon antibody, coupled to sepharose beads. True fasting pancreatic glucagon levels (mean+/-SEM) in 18 healthy subjects (24+/-3 pg/ml) were significantly lower (p less than .005) than in 10 non-ketotic non-obese diabetics (38+/-3 pg/ml). It is suggested that, in the presence of decreased insulin-effect in the diabetic, this 55% glucagon elevation in diabetics may be of biological importance and contribute to the fasting hyperglycaemia.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 838198     DOI: 10.1007/BF00996319

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  22 in total

1.  High molecular weight glucagon-like immunoreactivity in plasma.

Authors:  G C Weir; S D Knowlton; D B Martin
Journal:  J Clin Endocrinol Metab       Date:  1975-02       Impact factor: 5.958

2.  Glucagon metabolism in man, studies on the metabolic clearance rate and the plasma acute disappearance time of glucagon in normal and diabetic subjects.

Authors:  F P Alford; S R Bloom; J D Nabarro
Journal:  J Clin Endocrinol Metab       Date:  1976-05       Impact factor: 5.958

3.  Glucagon immunoassay using polyethylene glycol to precipitate antibody-bound hormone.

Authors:  J C Henquin; P Malvaux; A E Lambert
Journal:  Diabetologia       Date:  1974-02       Impact factor: 10.122

4.  Abnormalities of glucagon metabolism in untreated diabetes mellitus.

Authors:  K D Buchanan; A M McCarroll
Journal:  Lancet       Date:  1972-12-30       Impact factor: 79.321

5.  Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion.

Authors:  W A Müller; G R Faloona; E Aguilar-Parada; R H Unger
Journal:  N Engl J Med       Date:  1970-07-16       Impact factor: 91.245

6.  Determination of pancreatic and gut glucagon-like immunoreactivity (GLI) in normal and diabetic subjects.

Authors:  L G Heding; S M Rasmussen
Journal:  Diabetologia       Date:  1972-12       Impact factor: 10.122

7.  Reaction of insulin with ethyl glycinate and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide.

Authors:  H Ozawa
Journal:  Biochemistry       Date:  1970-05-12       Impact factor: 3.162

8.  Plasma enteroglucagon and plasma volume change after gastric surgery.

Authors:  J P Thomson; S R Bloom
Journal:  Clin Sci Mol Med       Date:  1976-08

9.  Nonketotic diabetes mellitus: insulin deficiency or insulin resistance?

Authors:  G M Reaven; R Bernstein; B Davis; J M Olefsky
Journal:  Am J Med       Date:  1976-01       Impact factor: 4.965

10.  Pancreatectomised man: A model for diabetes without glucagon.

Authors:  A J Barnes; S R Bloom
Journal:  Lancet       Date:  1976-01-31       Impact factor: 79.321

View more
  31 in total

1.  Adrenaline increases skeletal muscle glycogenolysis, pyruvate dehydrogenase activation and carbohydrate oxidation during moderate exercise in humans.

Authors:  M J Watt; K F Howlett; M A Febbraio; L L Spriet; M Hargreaves
Journal:  J Physiol       Date:  2001-07-01       Impact factor: 5.182

2.  Proliferative effects of 'fibre' on the intestinal epithelium: relationship to gastrin, enteroglucagon and PYY.

Authors:  R A Goodlad; W Lenton; M A Ghatei; T E Adrian; S R Bloom; N A Wright
Journal:  Gut       Date:  1987       Impact factor: 23.059

3.  Release of gastrointestinal hormones following an oral water load.

Authors:  N D Christofides; D L Sarson; R H Albuquerque; T E Adrian; M A Ghatei; I M Modlin; S R Bloom
Journal:  Experientia       Date:  1979-11-15

4.  Gut hormones in tropical malabsorption.

Authors:  H S Besterman; G C Cook; D L Sarson; N D Christofides; M G Bryant; M Gregor; S R Bloom
Journal:  Br Med J       Date:  1979-11-17

5.  Glucagon immunoreactivity in plasma from normal and dystrophic mice.

Authors:  B Ahrén; I Lundquist
Journal:  Diabetologia       Date:  1982-04       Impact factor: 10.122

6.  Measurement of gut hormonal peptides in biopsies from human stomach and proximal small intestine.

Authors:  M G Bryant; S R Bloom; J M Polak; S Hobbs; W Domschke; S Domschke; P Mitznegg; H Ruppin; L Demling
Journal:  Gut       Date:  1983-02       Impact factor: 23.059

7.  A new bioassay for glucagon.

Authors:  G Gagnon; D Regoli; F Rioux
Journal:  Br J Pharmacol       Date:  1978-09       Impact factor: 8.739

8.  Growth and endocrine changes in the hepatic glycogenoses.

Authors:  D B Dunger; A T Holder; J V Leonard; J Okae; M A Preece
Journal:  Eur J Pediatr       Date:  1982-05       Impact factor: 3.183

9.  Effect of portasystemic venous shunt surgery on hyperglucagonaemia in cirrhosis: paired studies of pre- and post-shunted subjects.

Authors:  F J Dudley; F P Alford; D J Chisholm; D M Findlay
Journal:  Gut       Date:  1979-10       Impact factor: 23.059

10.  The effect of selective and non-selective beta-adrenoceptor blockade, and of naloxone infusion, on the hormonal mechanisms of recovery from insulin-induced hypoglycaemia in man.

Authors:  J G Armitstead; S L Lightman; M J Brown; R C Causon; N J Vaughan
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.